Clonal Ph-negative hematopoiesis in CML after therapy with imatinib mesylate is frequently characterized by trisomy 8

被引：90

作者：

Andersen, MK

Pedersen-Bjorgaard, J

Kjeldsen, L

Dufva, IH

Brondum-Nielsen, K

机构：

[1] Rigshosp, Hematol Oncol Sect, Cytogenet Lab 4052, Dept Clin Genet, Copenhagen, Denmark

[2] Rigshosp, Dept Hematol, Copenhagen, Denmark

[3] Amtssygehuset, Dept Hematol, Herlev, Denmark

[4] John F Kennedy Inst, DK-2600 Glostrup, Denmark

来源：

LEUKEMIA | 2002年 / 16卷 / 07期

关键词：

D O I：

10.1038/sj.leu.2402634

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1390 / 1393

页数：4

共 21 条

[1] CLONAL ORIGIN OF PHILADELPHIA-CHROMOSOME NEGATIVE CELLS WITH TRISOMY-8 APPEARING DURING THE COURSE OF ALPHA-INTERFERON THERAPY FOR PH POSITIVE CHRONIC MYELOCYTIC-LEUKEMIA [J].

ARIYAMA, T ;

INAZAWA, J ;

UEMURA, Y ;

KAKAZU, N ;

MAEKAWA, T ;

URASE, F ;

IRIMAJIRI, K ;

HORIUCHI, A ;

NAKAMURA, Y ;

ABE, T .

CANCER GENETICS AND CYTOGENETICS, 1995, 81 (01) :20-23

[2] A 2ND CASE OF TRISOMY-8 IN PHILADELPHIA-CHROMOSOME (PH)-NEGATIVE CELLS DURING THE COURSE OF PH-POSITIVE CHRONIC MYELOCYTIC-LEUKEMIA [J].

BILHOUNABERA, C ;

MARIT, G ;

DEVIANNE, I ;

VIARD, F ;

SALZES, S ;

MONTASTRUC, M ;

RENOUX, M ;

BROUSTET, A ;

REIFFERS, J ;

BERNARD, P .

GENES CHROMOSOMES & CANCER, 1993, 6 (04) :255-256

[3] TRISOMY-8 IN PHILADELPHIA-CHROMOSOME (PH1)-NEGATIVE CELLS IN THE COURSE OF PH1-POSITIVE CHRONIC MYELOCYTIC-LEUKEMIA [J].

CASALI, M ;

TRUGLIO, F ;

MILONE, G ;

DIRAIMONDO, F ;

PARRINELLO, G ;

MASERATI, E ;

PASQUALI, F .

GENES CHROMOSOMES & CANCER, 1992, 4 (03) :269-270

[4] Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. [J].

Druker, BJ ;

Talpaz, M ;

Resta, DJ ;

Peng, B ;

Buchdunger, E ;

Ford, JM ;

Lydon, NB ;

Kantarjian, H ;

Capdeville, R ;

Ohno-Jones, S ;

Sawyers, CL .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (14) :1031-1037

[5] Emergence of new clonal abnormalities following interferon-alpha induced complete cytogenetic response in patients with chronic myeloid leukemia: Report of three cases [J].

Fayad, L ;

Kantarjian, H ;

OBrien, S ;

Seong, D ;

Albitar, M ;

Keating, M ;

Talpaz, M .

LEUKEMIA, 1997, 11 (05) :767-771

[6] CLONAL LYMPHOCYTES-B LACK BCR REARRANGEMENT IN PH-POSITIVE CHRONIC MYELOGENOUS LEUKEMIA [J].

FERRARIS, AM ;

CANEPA, L ;

MELANI, C ;

MIGLINO, M ;

BROCCIA, G ;

GAETANI, GF .

BRITISH JOURNAL OF HAEMATOLOGY, 1989, 73 (01) :48-50

[7] EVIDENCE FOR A MULTISTEP PATHOGENESIS OF CHRONIC MYELOGENOUS LEUKEMIA [J].

FIALKOW, PJ ;

MARTIN, PJ ;

NAJFELD, V ;

PENFOLD, GK ;

JACOBSON, RJ ;

HANSEN, JA .

BLOOD, 1981, 58 (01) :158-163

[8]

Gambacorti-Passeri C, 2001, BLOOD, V98, p257B

[9] RANDOMIZED COMPARISON OF BUSULFAN AND HYDROXYUREA IN CHRONIC MYELOGENOUS LEUKEMIA - PROLONGATION OF SURVIVAL BY HYDROXYUREA [J].

HEHLMANN, R ;

HEIMPEL, H ;

HASFORD, J ;

KOLB, HJ ;

PRALLE, H ;

HOSSFELD, DK ;

QUEISSER, W ;

LOFFLER, H ;

HEINZE, B ;

GEORGII, A ;

VONWUSSOW, P ;

BARTRAM, C ;

GRIESSHAMMER, M ;

BERGMANN, L ;

ESSERS, U ;

FALGE, C ;

HOCHHAUS, A ;

QUEISSER, U ;

SICK, C ;

MEYER, P ;

SCHMITZ, N ;

VERPOORT, K ;

EIMERMACHER, H ;

WALTHER, F ;

WESTERHAUSEN, M ;

KLEEBERG, UR ;

HEILEIN, A ;

KABISCH, A ;

BARZ, C ;

ZIMMERMANN, R ;

MEURET, G ;

TICHELLI, A ;

BERDEL, WE ;

KANZ, L ;

ANGER, B ;

TIGGES, FJ ;

SCHMID, L ;

BROCKHAUS, W ;

ZANKOVICH, R ;

SCHLAFER, U ;

WEISSENFELS, I ;

MAINZER, K ;

TOBLER, A ;

PERKER, M ;

HOHNLOSER, J ;

MESSENER, D ;

THIELE, J ;

BUHR, T ;

ANSARI, H .

BLOOD, 1993, 82 (02) :398-407

[10] RANDOMIZED COMPARISON OF INTERFERON-ALPHA WITH BUSULFAN AND HYDROXYUREA IN CHRONIC MYELOGENOUS LEUKEMIA [J].